Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 105 record(s)

Req # A 2020_0003

January 1, 2019 to present, internal and consultant reports on acquiring, managing, selling government assets or in taking an equity position in private companies. Provide January 1, 2020 to present, discussions, memos about administering financing/loans for large businesses that lead to the announced LEEFF program and a CDEV (CEEFC) administrative assigned role. Provide estimated CDEV (CEEFC) costs, including start-up costs to administer the LEEFF program over the next 5 years and preliminary work plans and budget, new evaluation and assessment procedures and terms and application forms for this new area of responsibilities. Include any summary of numbers and type of registrants/ number of applicants to date and projected and those accepted, on hold, and rejected. Include procedures and memos prepared should LEEFF loans need to become equity positions (that includes more on CEEFC compensation via warrants). Include data on consultants hired and their costs and terms of reference to review LEEFC applicants

Organization: Canada Development Investment Corporation

85 page(s)
April 2021

Req # A-2020-00112

List of subjects of all e-mails from an employee of the People, Culture and Environment Branch

Organization: Canada Economic Development for Quebec Regions

344 page(s)
April 2021

Req # A-2016-001449

Briefing materials on two topics - the Canada Health Transfer and on Federal/Provincial health funding negotiations/meetings. Time frame is since August 1, 2016.

Organization: Health Canada

347 page(s)
April 2021

Req # A-2017-000369

All reviewers' reports regarding the cleared New Drug Submission (NDS) for ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated] Manufactured by Baxalta.

Organization: Health Canada

152 page(s)
April 2021

Req # A-2017-001358

All records at an Assistant Deputy Minister (ADM) level or above regarding medical cannabis re: smoke, topicals and edibles from July - September 2017.

Organization: Health Canada

2 page(s)
April 2021

Req # A-2018-000701

Application under Substance Use and Addictions Program (SUAP) by the BC Centre for Disease Control (CDC) for a national surveillance system for monitoring the content of illegal drugs. All correspondence between Health Canada and the CDC regarding this proposal, from August 15, 2018.

Organization: Health Canada

287 page(s)
April 2021

Req # A-2018-000703

The application to Health Canada under the Substance Use and Addictions Program (SUAP) by the BC Centre for Disease Control (CDC) for a hydromorphone dispensing project, and any correspondence between Health Canada and the BC CDC about that project from December 1, 2017 to August 15, 2018.

Organization: Health Canada

217 page(s)
April 2021

Req # A-2018-001794

Systematic review of the association between perineal use of talc and ovarian cancer risk cited on p. 37 of the Draft Screening Assessment - Talc.

Organization: Health Canada

1306 page(s)
April 2021

Req # A-2019-001716

All records related to Health Canada's full Forward Regulatory Plans related to universal pharmacare, pharmacare and rare disease drug access.

Organization: Health Canada

27 page(s)
April 2021

Req # A-2019-001937

All communications briefing notes and presentations between Health Canada and other Federal government agencies regarding cannabis health products between July 1, 2019 and February 1, 2020.

Organization: Health Canada

26 page(s)
April 2021
Date modified: